Form 8-K - Current report:
SEC Accession No. 0001683168-24-008424
Filing Date
2024-11-27
Accepted
2024-11-27 16:03:13
Documents
15
Period of Report
2024-11-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT acon_8k.htm   iXBRL 8-K 41689
2 AMENDMENT NO. 1 TO COMMON STOCK PURCHASE AGREEMENT acon_ex1001.htm EX-10.1 46120
  Complete submission text file 0001683168-24-008424.txt   316522

Data Files

Seq Description Document Type Size
3 XBRL PRESENTATION FILE acon-20241127_pre.xml EX-101.PRE 25272
4 XBRL LABEL FILE acon-20241127_lab.xml EX-101.LAB 36765
5 XBRL DEFINITION FILE acon-20241127_def.xml EX-101.DEF 26648
6 XBRL SCHEMA FILE acon-20241127.xsd EX-101.SCH 3788
17 EXTRACTED XBRL INSTANCE DOCUMENT acon_8k_htm.xml XML 5794
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41358 | Film No.: 241510956
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)